BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6243953)

  • 1. Studies on the mechanism of adenosine 5'-monophosphate inhibition of bovine liver fructose 1,6-bisphosphatase.
    Stone SR; Fromm HJ
    Biochemistry; 1980 Feb; 19(4):620-5. PubMed ID: 6243953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate is enhanced by EDTA and diminished by zinc(II).
    Costas MJ; Cameselle JC
    Biochem Int; 1988 Apr; 16(4):747-53. PubMed ID: 2839191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling.
    Rakus D; Pasek M; Krotkiewski H; Dzugaj A
    Biochemistry; 2004 Nov; 43(47):14948-57. PubMed ID: 15554702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle FBPase in a complex with muscle aldolase is insensitive to AMP inhibition.
    Rakus D; Pasek M; Krotkiewski H; Dzugaj A
    FEBS Lett; 2003 Jul; 547(1-3):11-4. PubMed ID: 12860378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle aldolase decreases muscle FBPase sensitivity toward AMP inhibition.
    Rakus D; Dzugaj A
    Biochem Biophys Res Commun; 2000 Aug; 275(2):611-6. PubMed ID: 10964712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of FBPase with aldolase: a kinetic and fluorescence investigation on chicken muscle enzymes.
    Dziewulska-Szwajkowska D; Zmojdzian M; Dobryszycki P; Kochman M; Dzugaj A
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Jan; 137(1):115-29. PubMed ID: 14698918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central cavity of fructose-1,6-bisphosphatase and the evolution of AMP/fructose 2,6-bisphosphate synergism in eukaryotic organisms.
    Gao Y; Shen L; Honzatko RB
    J Biol Chem; 2014 Mar; 289(12):8450-61. PubMed ID: 24436333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic properties of D-fructose-1,6-bisphosphate 1-phosphohydrolase isolated from human muscle.
    Skalecki K; Mularczyk W; Dzugaj A
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):1029-35. PubMed ID: 7575399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition.
    Hines JK; Chen X; Nix JC; Fromm HJ; Honzatko RB
    J Biol Chem; 2007 Dec; 282(49):36121-31. PubMed ID: 17933867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin of the high sensitivity of muscle fructose 1,6-bisphosphatase towards AMP.
    Rakus D; Maciaszczyk E; Wawrzycka D; Ułaszewski S; Eschrich K; Dzugaj A
    FEBS Lett; 2005 Oct; 579(25):5577-81. PubMed ID: 16213487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity labeling of the allosteric site of fructose 1,6-bisphosphatase with an AMP analog.
    Sakai K; Kawashima S; Suzuki K; Imahori K
    J Biochem; 1987 Aug; 102(2):377-84. PubMed ID: 2822686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase.
    Han X; Huang Y; Zhang R; Xiao S; Zhu S; Qin N; Hong Z; Wei L; Feng J; Ren Y; Feng L; Wan J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():155-160. PubMed ID: 27137358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate.
    Pilkis SJ; El-Maghrabi MR; Pilkis J; Claus T
    J Biol Chem; 1981 Apr; 256(8):3619-22. PubMed ID: 6260770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance studies of fructose 2,6-bisphosphate and adenosine 5'-monophosphate interaction with bovine liver fructose-1,6-biphosphatase.
    Ganson NJ; Fromm HJ
    J Biol Chem; 1985 Mar; 260(5):2837-43. PubMed ID: 2982838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed mutations in the poorly defined region of porcine liver fructose-1,6-bisphosphatase significantly affect catalysis and the mechanism of AMP inhibition.
    Kurbanov FT; Choe JY; Honzatko RB; Fromm HJ
    J Biol Chem; 1998 Jul; 273(28):17511-6. PubMed ID: 9651342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA sequence and kinetic properties of human lung fructose(1, 6)bisphosphatase.
    Skalecki K; Rakus D; Wiśniewski JR; Kolodziej J; Dzugaj A
    Arch Biochem Biophys; 1999 May; 365(1):1-9. PubMed ID: 10222032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivities of mutants and chimeric forms of human muscle and liver fructose-1,6-bisphosphatases towards AMP.
    Rakus D; Tillmann H; Wysocki R; Ulaszewski S; Eschrich K; Dzugaj A
    Biol Chem; 2003 Jan; 384(1):51-8. PubMed ID: 12674499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli: distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch.
    Hines JK; Kruesel CE; Fromm HJ; Honzatko RB
    J Biol Chem; 2007 Aug; 282(34):24697-706. PubMed ID: 17567577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of bovine liver fructose-1,6-bisphosphatase.
    Casazza JP; Stone SR; Fromm HJ
    J Biol Chem; 1979 Jun; 254(11):4661-5. PubMed ID: 220258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution.
    Liang JY; Huang S; Zhang Y; Ke H; Lipscomb WN
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2404-8. PubMed ID: 1312721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.